ArticleScientific reports2025
A cross-sectional analysis of remnant cholesterol-diabetes association in US adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A novel score to evaluate nonlinear association between insulin resistance and new-onset diabetes mellitus: A cohort analysis.Medicine · 2026Article
- Association of mid-pregnancy remnant cholesterol levels with adverse pregnancy outcomes in women with gestational diabetes mellitus.BMC pregnancy and childbirth · 2026Article
- Association between the remnant cholesterol and the risk of new-onset chronic diseases: evidence from CHARLS.Diabetology & metabolic syndrome · 2026Article
- A Narrative Review of Remnant Cholesterol as an Independent Atherogenic Lipoprotein in Type 2 Diabetes: Pathophysiology and Clinical Implications.Therapeutics and clinical risk management · 2026Review
- Cumulative of c-reactive protein-triglyceride glucose index exposure and risk of diabetes in middle-aged and older Chinese adults: findings from a national longitudinal cohort.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between remnant cholesterol and diabetes is a critical issue in the fields of health and public health. Currently, the relationship between remnant cholesterol (RC) and diabetes is a highly researched and trending topic. The aim of this study was to investigate association between RC and diabetes in US individuals. The secondary objective of this study was to explore the potential dose-response relationship between the exposure RC and diabetes. Our study utilized all available continuous data from the National Health and Nutrition Examination Survey (NHANES) from 2013 to 2018. Multivariable logistic regression models were used to investigate the association between RC and diabetes. The association between RC and diabetes was assessed using smoothing splines generated by generalized additive models. Additionally, a threshold effect analysis of the relationship between RC and diabetes was conducted. Analysis of 6,875 eligible adults (derived from an initial cohort of 7,780 after exclusions for missing diabetes/cholesterol data) revealed a significant threshold effect at 19 mg/dLof remnant cholesterol (RC) for diabetes prevalence. Participants with RC < 19 mg/dL exhibited substantially elevated diabetes odds in both unadjusted (OR = 1.80, 95% CI: 1.57-2.06; P < 0.001) and fully adjusted models (OR = 1.46, 95% CI: 1.30-1.64; P < 0.001), whereas RC ≥ 19 mg/dL demonstrated no significant association (adjusted OR = 0.99, 95% CI: 0.88-1.25; P = 0.96). Quartile analysis confirmed a robust dose-dependent relationship: compared to Quartile 1 (RC ≤ 12 mg/dL; reference), diabetes odds progressively increased to OR = 1.72 (95% CI: 1.37-2.16)for Quartile 2 (13-18 mg/dL), OR = 2.32 (95% CI: 1.86-2.91) for Quartile 3 (19-26 mg/dL), and OR = 3.42 (95% CI: 2.77-4.21)for Quartile 4 (27-80 mg/dL), with significant trend persistence after multivariable adjustment (P < 0.001). These associations remained significant despite substantial demographic variations across RC quartiles, including differences in age (P < 0.001), sex distribution (P < 0.001), and racial/ethnic composition (P < 0.001). This cross-sectional analysis observed that elevated RC levels were significantly associated with higher prevalence of diabetes in adults aged 20-80 years, with a threshold value of 19 mg/dL for increased association strength. The findings support RC as a metabolic marker associated with prevalent diabetes with a threshold value of 19 mg/dL for strengthened association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.